David C Gammon

Summary

Affiliation: University of Massachusetts Medical School
Country: USA

Publications

  1. ncbi Safety and cost-effectiveness of paclitaxel administered as a 1-hour infusion versus a 3-hour infusion for various malignancies
    David C Gammon
    Department of Pharmacy, University Campus, UMass Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA
    J Infus Nurs 27:251-3. 2004
  2. ncbi Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol
    David Gammon
    UMass Memorial Medical Center, 55 Lake Avenue North, Worcester, Massachusetts 01655, USA
    Oncologist 9:546-9. 2004
  3. ncbi Intrathecal topotecan in adult patients with neoplastic meningitis
    David C Gammon
    Department of Pharmacy, UMass Memorial Medical Center, University Campus, Worcester, MA 01655, USA
    Am J Health Syst Pharm 63:2083-6. 2006
  4. ncbi Managing reduced methotrexate clearance in a patient with a heterozygous methylenetetrahydrofolate reductase gene polymorphism
    David C Gammon
    Umass Memorial Medical Center University Campus, Worcester, MA 01655, USA
    J Oncol Pharm Pract 14:153-6. 2008
  5. ncbi Intraurethral fluorouracil and lidocaine for intraurethral condyloma acuminata
    David C Gammon
    Department of Pharmacy, University of Massachusetts Memorial Medical Center, Worcester, MA 01655, USA
    Am J Health Syst Pharm 65:1830-3. 2008
  6. ncbi Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy
    Donald A Hutcherson
    Department of Pharmacy, Emory Healthcare, Atlanta, Georgia, USA
    Pharmacotherapy 26:242-7. 2006
  7. ncbi Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis
    David C Gammon
    Pharmacy Consultant II, Clinical Pharmacy Services, Commonwealth Medicine, University of Massachusetts Medical School, Worcester, MA 01545, USA
    Am J Health Syst Pharm 66:1186-90. 2009

Collaborators

Detail Information

Publications7

  1. ncbi Safety and cost-effectiveness of paclitaxel administered as a 1-hour infusion versus a 3-hour infusion for various malignancies
    David C Gammon
    Department of Pharmacy, University Campus, UMass Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA
    J Infus Nurs 27:251-3. 2004
    ..Over a 2-year period, the authors were able to document significant time savings with no increase in adverse drug reactions...
  2. ncbi Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol
    David Gammon
    UMass Memorial Medical Center, 55 Lake Avenue North, Worcester, Massachusetts 01655, USA
    Oncologist 9:546-9. 2004
    ..The desensitization protocol is described in detail...
  3. ncbi Intrathecal topotecan in adult patients with neoplastic meningitis
    David C Gammon
    Department of Pharmacy, UMass Memorial Medical Center, University Campus, Worcester, MA 01655, USA
    Am J Health Syst Pharm 63:2083-6. 2006
    ..The efficacy and safety of intrathecal topotecan were assessed in patients with neoplastic meningitis (NM) by retrospective chart review...
  4. ncbi Managing reduced methotrexate clearance in a patient with a heterozygous methylenetetrahydrofolate reductase gene polymorphism
    David C Gammon
    Umass Memorial Medical Center University Campus, Worcester, MA 01655, USA
    J Oncol Pharm Pract 14:153-6. 2008
    ..This case report illustrates the feasibility of administering high dose methotrexate with modifications as a treatment of choice in individuals with methylenetetrahydrofolate reductase gene mutations...
  5. ncbi Intraurethral fluorouracil and lidocaine for intraurethral condyloma acuminata
    David C Gammon
    Department of Pharmacy, University of Massachusetts Memorial Medical Center, Worcester, MA 01655, USA
    Am J Health Syst Pharm 65:1830-3. 2008
    ..A new and convenient means of administering fluorouracil and lidocaine for the treatment of intraurethral condyloma acuminata is discussed...
  6. ncbi Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy
    Donald A Hutcherson
    Department of Pharmacy, Emory Healthcare, Atlanta, Georgia, USA
    Pharmacotherapy 26:242-7. 2006
    ..In most of the patients, a single 6-mg dose of rasburicase was effective in correcting uric acid levels in the typical time between diagnosis and start of antineoplastic therapy...
  7. ncbi Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis
    David C Gammon
    Pharmacy Consultant II, Clinical Pharmacy Services, Commonwealth Medicine, University of Massachusetts Medical School, Worcester, MA 01545, USA
    Am J Health Syst Pharm 66:1186-90. 2009
    ..Cytoreductive surgery (CS) and intraperitoneal hyperthermic chemotherapy (IPHC) in the treatment of peritoneal carcinomatosis (PC) in 15 patients are described...